Yutaka Okada

Yutaka Okada is an accomplished executive with extensive experience in the pharmaceutical and healthcare industries. Currently serving as President and Representative Director of Alnylam Japan KK since June 2022, Yutaka has held various senior leadership roles, including President of Galderma KK and The Proactiv Company, and Head of Hematology Franchise at Takeda. Prior experience includes significant positions at Shire, Boehringer Ingelheim, GlaxoSmithKline, and Astellas Pharma, where Yutaka managed multiple business units and marketing functions. Yutaka's educational background includes an MBA in Marketing and Strategy from the University of Pittsburgh and a Bachelor's degree from Seikei University.